Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CORONAVIRUS (COVID-19)

If you are a participant or have a participant with fever, cough or shortness of breath returning a 24hr monitor to the Oxford Monitoring team, please place equipment into two bags prior to sending using the prepaid envelope. This enables us to handle it in accordance to the Public Health England guidelines for COVID-19. All CPSD clinics follow Oxford University NHS Trust infection control guidelines.

Further information about COVID-19 can be found at https://www.gov.uk/government/topical-events/coronavirus-covid-19-uk-government-response

Contingency Plan

https://www.nihr.ac.uk/documents/restart-framework/24886

Prevention of hypertensive injury to the brain by intensive treatment in intracerebral haemorrhage

currently  RECRUITing participants -  50 randomised as of 11/02/2021 (5 UCL, 3 IMPERIAL, 4 ST GEORGES , 6 OXFORD, 3 glasgow, 1 salford, 3 Sheffield, 7 kings, 6 Edinburgh, 3 nottingham, 9 Addenbrookes)

Prevention of Hypertensive Injury to the Brain by Intensive Treatment after Intracerebral haemorrhage: a pilot randomised trial of home telemetry-guided treatment.

OXFORD TEAM

The trial will show whether intensive lowering of blood pressure (BP) using telemetric home monitoring in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful this study will be a precursor for a larger definitive trial. Our intervention should allow survivors of ICH to know, understand, and manage their own BP to prevent strokes and cognitive impairment, and improve outcomes.

PROHIBIT-ICH will randomise participants to compare a strategy of intensive BP treatment (target <120/80 mm Hg) guided by telemetric home monitoring, versus standard primary care (current RCP guideline is 130/80 mm Hg), in 112 adult survivors of hypertension-related ICH. We will establish the feasibility and safety of the intervention, the efficacy of BP reduction, and explore whether it reduces the progression of small vessel disease (SVD) related injury on brain MRI.


UCL TEAM